Cite this article

NIDA. (2017, August 28). Collaborative care shows promise for opioid and alcohol use disorders. Retrieved from https://archives.drugabuse.gov/news-events/news-releases/2017/08/collaborative-care-shows-promise-opioid-alcohol-use-disorders

press ctrl+c to copy

Science Spotlight

August 28, 2017

A NIDA-funded randomized clinical trial found that primary care patients with opioid and alcohol use disorders (OAUD) who were offered a collaborative care intervention were more likely to receive evidence-based treatment and refrain from using opioids and alcohol six months later, compared to patients receiving usual care.

Dr writing a prescriptionSource: Footage Firm, Inc

The collaborative care intervention increased both the proportion of patients receiving evidence-based treatment for OAUD (39.0% vs. 16.8%) and the number refraining from opioids or alcohol use at six months. (32.8% vs. 22.3%). Collaborative care was designed to increase the delivery of either a six-session brief psychotherapy treatment, and/or medication-assisted treatment, with either buprenorphine/naloxone for opioid use disorders or long-acting injectable naltrexone for alcohol use disorders. Usual care participants were given a number for appointment scheduling and a list of community referrals for OAUD treatment.

The authors suggest the findings indicate that treatment for OAUDs can be integrated into primary care settings effectively.

For a copy of the paper go to — "Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial"— published in JAMA Internal Medicine.

For information about opioids, go to: https://www.drugabuse.gov/drugs-abuse/opioids. For information about alcohol, go to: https://www.drugabuse.gov/drugs-abuse/alcohol.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245. Follow NIDA on Twitter and Facebook

-->